Scarica l'app Stockscreener
3.14
1.57%
-0.05
Dopo l'orario di chiusura:
3.14
Ac Immune Sa Borsa (ACIU) Ultime notizie
AC Immune secures CHF 10 million from Lilly to advance Alzheimer’s therapy - Greater Geneva Bern area
AC Immune revises collaboration with Eli Lilly on tau-targeting Alzheimer’s therapy - MSN
ACIU stock rallies 16.3% in a week: Here's what you need to know - MSN
Leerink Says AC Immune (ACIU) Eli Lilly Tau Program Amendment Is Great News - Insider Monkey
5 Best Strong Buy European Stocks to Invest In - Insider Monkey
Resistance Check: Can AC Immune SA weather a recessionQuarterly Trade Review & Smart Investment Allocation Tips - baoquankhu1.vn
ACIU Stock Rallies 16.3% in a Week: Here's What You Need to Know - TradingView
Can AC Immune SA reach resistance levels soonWeekly Trade Summary & Safe Entry Zone Identification - baoquankhu1.vn
Fed Watch: Will AC Immune SA stock hit new highs in YEARTrade Entry Report & Low Risk Investment Opportunities - baoquankhu1.vn
April 2026's Most Promising Penny Stocks - Yahoo Finance
Leerink reiterates AC Immune stock rating on Lilly deal amendment By Investing.com - Investing.com Canada
Why AC Immune Stock Zoomed Almost 15% Higher Today - Yahoo Finance
Leerink reiterates AC Immune stock rating on Lilly deal amendment - Investing.com
AC Immune stock surges on amended Lilly collaboration deal - Investing.com
AC Immune stock surges on amended Lilly collaboration deal By Investing.com - Investing.com South Africa
AC Immune amends license and collaboration deal with Lilly - The Pharma Letter
AC Immune rises after amending licensing deal with Lilly - Seeking Alpha
AC Immune, Lilly Amend Morphomer Tau Alliance - Contract Pharma
AC Immune amends Lilly collaboration, plans tau drug studies By Investing.com - Investing.com South Africa
AC Immune Secures Amended Tau Drug Collaboration with Lilly, Adds CHF 10 Million Upfront - TipRanks
According to the latest revised agreement terms, AC Immune SA will receive a total upfront payment of 10 million Swiss francs. - Bitget
AC Immune (NASDAQ: ACIU) amends Lilly Tau deal with CHF 10m upfront - Stock Titan
AC Immune amends Lilly collaboration, plans tau drug studies - Investing.com
AC Immune announces amendment to Morphomer® tau license and collaboration agreement with Lilly - marketscreener.com
AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly - The Manila Times
ACIU Technical Analysis & Stock Price Forecast - Intellectia AI
ACIU Stock Price, Quote & Chart | AC IMMUNE SA (NASDAQ:ACIU) - ChartMill
AC Immune (ACIU) director Zuegel reports options and RSU-based share stakes - Stock Titan
Exit Recap: Can AC Immune SA deliver consistent EPS growthWeekly Trend Report & Smart Investment Allocation Tips - baoquankhu1.vn
Is AC Immune (ACIU) outperforming other medical stocks this year? - MSN
Ideas Watch: What is the long term forecast for AC Immune SA stockRate Cut & Entry and Exit Point Strategies - baoquankhu1.vn
ACIU SEC FilingsAC Immune 10-K, 10-Q, 8-K Forms - Stock Titan
AC Immune Posts 2025 Results, Sharpens Pipeline Focus and Extends Cash Runway to 2027 - TipRanks
AC Immune FY 2025 Results: Eyeing ACI-7104 Catalysts - seekingalpha.com
Trading Recap: Will AC Immune SA stock hit new highs in YEAR2026 Investor Takeaways & Fast Gain Swing Alerts - baoquankhu1.vn
AC Immune (ACIU) COO Piergiorgio Donati reports shares and long-dated options - Stock Titan
AC Immune shows first brain images of TDP-43 pathology in trial - Investing.com India
ACIU Unveils Promising Phase 1 Data for TDP-43 PET Imaging - GuruFocus
AC Immune Presents First In vivo Images of Brain TDP-43 - GlobeNewswire
Aug Volume: Does AC Immune SA outperform in volatile markets2026 Price Momentum & Growth Oriented Trading Recommendations - baoquankhu1.vn
AC Immune (ACIU) CFO discloses common shares, RSUs and option grants - Stock Titan
AC Immune (NASDAQ: ACIU) director Monika Buetler details initial share and option holdings - Stock Titan
AC Immune (NASDAQ: ACIU) director reports initial Form 3 holdings - Stock Titan
[Form 3] AC Immune SA Initial Statement of Beneficial Ownership - Stock Titan
AC Immune (ACIU) CEO discloses equity and option holdings - Stock Titan
AC Immune (ACIU) director June Carl Howard details share and option stakes - Stock Titan
AC Immune (ACIU) Upgraded to Buy: Here's Why - Yahoo Finance
Is AC Immune (ACIU) Outperforming Other Medical Stocks This Year? - Yahoo Finance
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):